INNV · InnovAge Holding Corp. · Executive Compensation
$8.80
+0.00 (+0.00%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$1.23B
Shares
136.45M
Volume · Oct 1
461.96K
Avg daily vol (3M)
420.03K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Patrick Blair | Chief Executive Officer | $1,547,000 |
| Michael Scarbrough | President and Chief Operating Officer | $1,473,671 |
| Nicole D’Amato | Chief Legal Officer and Corporate Secretary | $766,120 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Patrick Blair | President and Chief Executive Officer | $4,940,894 |
| Benjamin Adams | Chief Financial Officer | $2,513,435 |
| Nicole D’Amato | Chief Legal Officer and Corporate Secretary | $1,609,534 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Patrick Blair | President and Chief Executive Officer | $1,506,600 |
| Nicole D’Amato | Chief Legal Officer and Corporate Secretary | $1,478,770 |
| Richard Feifer | Chief Medical Officer | $1,338,689 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Patrick Blair | President and Chief Executive Officer | $7,673,474 |
| Maureen Hewitt | Former Chief Executive Officer | $3,305,307 |
| Nicole D’Amato | Chief Legal Officer and Corporate Secretary | $1,596,995 |
| Barbara Gutierrez | Chief Financial Officer | $625,448 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Maureen Hewitt | Former Chief Executive Officer | $40,889,539 |
| Barbara Gutierrez | Chief Financial Officer | $9,683,562 |
| Maria Lozzano | Corporate Chief Operating Officer | $3,755,032 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Maureen Hewitt | President and Chief Executive Officer | $1,646,731 |
| Barbara Gutierrez | Chief Financial Officer | $932,645 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jennifer Browne | President and Chief Operating Officer | Appointed | 2026-05-12 |
| Sean Traynor | Class I director | Appointed | 2026-01-29 |
| Pavithra Mahesh | Class III director | Appointed | 2026-01-29 |
| Michael Scarbrough | President and Chief Operating Officer | Terminated | 2025-10-23 |
| Maria Lozzano | President, Pharmacy Services | Appointed | 2024-11-04 |
| Patrick Blair | Chief Operating Officer | Resigned | 2024-11-04 |
| Michael Scarbrough | President and Chief Operating Officer | Appointed | 2024-11-04 |
| Sean Traynor | member of the Board | Resigned | 2023-08-14 |
| Teresa Sparks | Chair of the Audit Committee | Appointed | 2023-08-14 |
| Teresa Sparks | Class II director | Appointed | 2023-08-14 |
| Ben Adams | Chief Financial Officer (CFO) | Appointed | 2023-07-05 |
| Pavithra Mahesh | member of the Board | Resigned | 2023-03-30 |
| Caroline Dechert | member of the Board | Resigned | 2023-03-30 |
| Patricia "Patty" Fontneau | Class III director | Appointed | 2023-03-30 |
| Maria Lozzano | Senior Advisor to the Chief Executive Officer | Appointed | 2023-03-01 |
| Christine Bent | Chief Operations Officer | Appointed | 2023-03-01 |